ApoB counts the actual number of artery-clogging particles in your blood, because every LDL, VLDL, IDL and Lp(a) particle carries exactly one copy of this protein. Many lipid specialists now consider it the single most informative number on a cholesterol panel.
Standard range versus optimal range
| Framework | ApoB value | Source |
|---|---|---|
| Standard lab reference | 60-130 mg/dL | Common US laboratory range |
| Guideline target for very high risk | below 80 mg/dL | 2019 ESC/EAS guideline |
| Optimal for longevity | below 65-80 mg/dL | Functional medicine consensus |
When it runs high
A high ApoB means a high traffic load of atherogenic particles, and each one can slip into the artery wall and seed plaque. Risk rises gradually and continuously with the particle count rather than jumping at one cutoff.
- Diet rich in saturated fat and refined carbohydrate
- Insulin resistance or type 2 diabetes
- Familial hypercholesterolemia or other genetic lipid disorders
- Hypothyroidism
- Nephrotic syndrome or chronic kidney disease
- Certain medicines such as androgens, progestins, some diuretics and beta blockers
When it runs low
A low ApoB is almost always good news and simply reflects few circulating atherogenic particles. Clinically relevant low values are rare and usually point to another underlying condition rather than a problem caused by ApoB itself.
- Malnutrition or severe underweight
- Overactive thyroid
- Advanced liver disease
- Rare inherited conditions such as hypobetalipoproteinemia
What ApoB actually measures
Cholesterol itself does not float freely in blood. It travels inside lipoprotein particles, and every particle that can enter the artery wall carries exactly one ApoB protein on its surface. Measuring ApoB therefore counts particles directly instead of estimating how much cholesterol they happen to hold. Two people with identical LDL cholesterol values can carry very different particle numbers, and the person with more particles faces more risk.
Why particle number beats cholesterol content
Plaque forms one particle at a time, so the probability of disease tracks the number of particles and how long they circulate. Large outcome datasets show that ApoB separates high risk from low risk more accurately than LDL cholesterol, especially when triglycerides are elevated or diabetes is present. This discordance matters most in metabolic syndrome, where LDL cholesterol can look reassuring while ApoB quietly runs high.
Bringing ApoB down
The levers that lower ApoB are well established. Statins, ezetimibe and PCSK9-targeted medicines all reduce particle production or speed their clearance. Weight loss, replacing saturated fat with unsaturated fat, adding viscous fiber and treating insulin resistance each move the number meaningfully. Because ApoB responds within weeks, a follow-up test six to eight weeks after a change shows whether the plan is working.
Related calculators
Related biomarkers LDL · Lp(a) · Triglycerides · ApoA1